This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Response to chemotherapy

Arch Intern Med. 1971;128(3):333-344.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In vitro studies of a cancer patient's immune response before and after chemotherapy may give some indication of his chances of survival and the effects of the treatment on his tumor.

In addition, according to Jules Harris, MD, of the University of Ottawa, there appears to be a "vulnerable period" six to nine days after the completion of a course of chemotherapy during which stimulation of the immune response might prolong the interval between courses of chemotherapy, perhaps even leading to prolonged remission.

Dr. Harris, who is an assistant professor of medicine and director of the laboratory of immunology at the University of Ottawa, and A.R. Cheema, MD, of the Department of Developmental Therapeutics, M.D. Anderson Hospital and Tumor Institute, Houston, reported some of their results at the Chicago meeting of the Society for Clinical Oncology. Dr. Cheema's co-worker is E.R. Hersh, MD.

Dr. Cheema's study involved 40 patients whose . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?